Is there a role for PD-1 inhibitors for metastatic or locally recurrent cutaneous squamous cell carcinomas after failure of first line therapy, EGFR inhibitors?
Is it commonly used if no clinical trials are available?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Texas Southwestern
Answered on
Yes. response rate close to 50%. Look at ASCO abstract from 2017 phase 1 looking at new PD-1 inhibitor in treat this disease
Join for free or sign in to see the full answer